Navigation Links
Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
Date:12/12/2012

D processes.

“Toxicogenomics research is generating large amounts of complex omics data and researchers are challenged to make sense of these data,” noted Prof. Dr. Jos Kleinjans, scientific director of the Netherlands Toxigenomic Centre, who is the coordinator of the carcinoGENOMICS Project. “Genedata Expressionist helps researchers to effectively meet these challenges, by efficiently analyzing high-throughput molecular profiling data” continued Kleinjans. “Moreover, the Genedata team of scientists provides the necessary expertise to ensure the success of ambitious projects such as ours.”

Researchers use Genedata Expressionist to assess assay reproducibility and predict compound carcinogenicity. Assays are based on the application of omics technologies (i.e. genome-wide transcriptomics and metabolomics) to robust in vitro systems (rat/human). Phenotypic markers for genotoxic and carcinogenic events are assessed to anchor gene expression modulations, metabolic profiles, and mechanistic pathways. Through extensive biostatistics, literature mining, and analysis of molecular-expression datasets, differential genetic pathways are identified, which are capable of predicting mechanisms of chemical carcinogenesis in vivo. Furthermore, Genedata Expressionist is able to integrate transcriptomics and metabolomics data to provide a holistic understanding of systems biology and build an iterative in silico model of chemical carcinogenesis.

Recently, Genedata also contributed its software solutions to a number of innovative EU-funded, oncology-focused projects, including:

  •     NewGeneris – the consortium successfully investigated chemical risks concerning the development of childhood cancer and immune disorders and the role of prenatal exposure to genotoxic chemicals through maternal intake of food during pregnancy.
  •     INCA – the consortium successfully examin
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Genedata Screener to Present at 10th Annual Ion Channel Retreat
2. First detailed timeline established for brains descent into Alzheimers
3. infirst HEALTHCARE Established to Launch Novel Consumer Medicines
4. Newly-Published Study Compares SURFAXIN LS™ and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome
5. Quality Standards Established for Competition to Identify Best Researchers in the US
6. Rigaku ZSX Primus Application Note: Lubricating Oil Analysis by WDXRF According to ASTM D6443-04
7. Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform
8. Sulfur Analysis in Crude Oil and High-Sulfur Fuels by WDXRF According to ASTM D2622-10
9. VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
10. Global Medical Image Analysis Software Market Worth $2.4 Billion by 2017
11. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 Local veterinarian, Dr. ... Hospital are seeking candidates to participate in an investigational ... The ultimate goal of this study is to ... into one or two arthritically affected joints can help ... , Candidates for the current investigational study must be ...
(Date:8/29/2014)... 29, 2014 Intrinsic Imaging, an ... GAMP® 5 compliant imaging core lab, announced today ... II clinical trial to assess a new treatment ... trial, Intrinsic Imaging will provide comprehensive imaging core ... and charter development, site qualification, site training and ...
(Date:8/28/2014)... 2014 “This kit has an improved extraction ... 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin Product ... to plant owners and USDA-GIPSA inspection agencies that have a ... can take place in a matter of minutes with nothing ... test the feed and grain before accepting it, but they ...
(Date:8/28/2014)... PA (PRWEB) August 28, 2014 The ... create a culture that will allow individuals to perform ... becoming increasingly important for employers looking to compete in ... industries are embracing this trend, as the sector increasingly ... of a company, which will have real results on ...
Breaking Biology Technology:Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3
... Calif., Feb. 4 NeurogesX, Inc. (Nasdaq: ... commercializing novel pain management therapies, announced today that Anthony ... present at the 11th Annual BIO CEO & Investor ... 2009. Mr. DiTonno and Stephen Ghiglieri, Chief Financial Officer, ...
... Texcel,s custom medical device development and manufacturing ... the commercialization of their surgical, interventional, and implantable ... full array of services and technologies at the ... booth # 314.Texcel provides the manufacturing infrastructure and ...
... Art,s Way Manufacturing, Inc. (Nasdaq: ARTW ... Scientific, Inc. - Buildings For Science - has ... The new site, reflective of the company,s ... more user-friendly.Art,s Way Scientific ( http://www.buildingsforscience.com ) is ...
Cached Biology Technology:NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 2NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 3Texcel Highlights Medical Device Development & Manufacturing Solutions at MD&M West, booth 314 2Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 2Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 3
(Date:8/28/2014)... A unique method for delivering compounds that ... HIV and AIDS may be possible, thanks ... Agricultural Sciences., A semi-soft vaginal suppository made ... loaded with the antiviral drug Tenofovir provides ... against the spread of sexually transmitted infections ...
(Date:8/28/2014)... new roads will be built worldwide by 2050. Many ... where they bring an influx of destructive loggers, hunters ... has created a ,global roadmap, for prioritising road building ... demands of development and environmental protection. , The map ... natural importance of ecosystems and a ,road-benefits, layer that ...
(Date:8/28/2014)... more action is needed to ensure safeguards are in ... in PLOS ONE , researchers from Monash University, ... - combining results from different studies - to look ... areas, to determine whether they actually protect biodiversity. ... protecting an area from human exploitation made common sense, ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3Protected areas proven to protect biodiversity 2
... 26 October 2008 Arpida (SWX: ARPN) today ... III clinical trials at the 48th Interscience Conference ... of America (IDSA) 46th annual meeting in Washington, ... antibiotic, showed high clinical cure rates which were ...
... 2008 -- The Soil Science Society of America (SSSA) recognized ... special Awards Ceremony during their Annual Meeting on Oct. 5-9 ... colleagues based on their professional achievements and meritorious service. Only ... be elected Fellow. The 2008 class of SSSA Fellows are: ...
... Berlin, Germany Current research suggests that stress may ... skin disease. The related report by Joachim et ... Cells towards Maturation and Migration: Key role of ICAM-1/LFA-1 ... American Journal of Pathology . Skin provides the ...
Cached Biology News:Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections 2Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections 3Soil Science Society of America presents 2008 fellows 2Soil Science Society of America presents 2008 fellows 3Soil Science Society of America presents 2008 fellows 4Soil Science Society of America presents 2008 fellows 5Stress may make you itch 2
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
D-biotin *50 mM aqueous solution* Secondary Detection Biotin–Avidin Detection Reagents Other...
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: